E178: Elon Musk of Biotech: How David Berry Built 7 Unicorns
David Berry is one of the most prolific healthcare entrepreneurs of our time. In this episode, we discuss his transition from scientist to founder to investor, what it takes to scale transformational health companies, and how his firm Averin is helping usher in the next wave of AI-enabled healthcare. We also talk…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from How I Invest with David Weisburd
See all episodes →
36%E451: Peter Thiel's 27-Year Partner on the AI Bubble, the Venture Capital Crisis, and the PayPal Mafia
36%E449: Federated Hermes CEO on $400 Billion in Cash, the Private Markets Boom, and AI
34%E454: True Anomaly’s Even Rogers on Space Warfare, China’s Military Advantage, and the Defense Tech Boom
Similar episodes from other shows
More like How I Invest with David Weisburd →
D.A. Wallach Explains Why Biotech VC Is So Different
Y Combinator CEO Garry Tan: Turning Ambitious Misfits into Founders
Most Businesses Should Never Raise Venture Capital | Navin Goyal
#35: James Dyson: Defying Experts, Ignoring Focus Groups, and Betting on Big Ideas
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.